Article

A Randomized Controlled Pilot Trial of Oral N-Acetylcysteine in Children with Autism

Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California 94305, USA.
Biological psychiatry (Impact Factor: 10.26). 02/2012; 71(11):956-61. DOI: 10.1016/j.biopsych.2012.01.014
Source: PubMed

ABSTRACT

An imbalance in the excitatory/inhibitory systems with abnormalities in the glutamatergic pathways has been implicated in the pathophysiology of autism. Furthermore, chronic redox imbalance was also recently linked to this disorder. The goal of this pilot study was to assess the feasibility of using oral N-acetylcysteine (NAC), a glutamatergic modulator and an antioxidant, in the treatment of behavioral disturbance in children with autism.
This was a 12-week, double-blind, randomized, placebo-controlled study of NAC in children with autistic disorder. Subjects randomized to NAC were initiated at 900 mg daily for 4 weeks, then 900 mg twice daily for 4 weeks and 900 mg three times daily for 4 weeks. The primary behavioral measure (Aberrant Behavior Checklist [ABC] irritability subscale) and safety measures were performed at baseline and 4, 8, and 12 weeks. Secondary measures included the ABC stereotypy subscale, Repetitive Behavior Scale-Revised, and Social Responsiveness Scale.
Thirty-three subjects (31 male subjects, 2 female subjects; aged 3.2-10.7 years) were randomized in the study. Follow-up data was available on 14 subjects in the NAC group and 15 in the placebo group. Oral NAC was well tolerated with limited side effects. Compared with placebo, NAC resulted in significant improvements on ABC irritability subscale (F = 6.80; p < .001; d = .96).
Data from this pilot investigation support the potential usefulness of NAC for treating irritability in children with autistic disorder. Large randomized controlled investigations are warranted.

Download full-text

Full-text

Available from: Lawrence Fung
  • Source
    • "The primary outcome measure of the ASD phenotype and social interactions in participants with ASD was the parent-rated SRS total raw score. The SRS is a standardized , 65-item measure of the core symptoms of ASD where each item is scored on a 4-point scale, which has been used extensively in ASD research35363738. The SRS was administered at screen, baseline, week 6 (after 5 weeks of SST), and at week 11 (after 10 weeks of social skills training). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Researchers have demonstrated that d-cycloserine (DCS) can enhance the effects of behavioral interventions in adults with anxiety and enhances prosocial behavior in animal models of autism spectrum disorders (ASD). This study extended upon this background by combining DCS with behavioral social skills therapy in youth with ASD to assess its impact on the core social deficits of ASD. We hypothesized that DCS used in combination with social skills training would enhance the acquisition of social skills in children with ASD. Methods: A 10-week, double-blind, placebo-controlled trial of DCS (50 mg) given 30 min prior to weekly group social skills training was conducted at two sites. Children with ASD were randomized to receive 10 weeks (10 doses) of DCS or placebo in a 1:1 ratio. Results: No statistically significant difference attributable to drug treatment was observed in the change scores for the primary outcome measure, the Social Responsiveness Scale (SRS), total score (p = 0.45), or on secondary outcome measures. Conclusions: The results of this trial demonstrated no drug-related short-term improvement on the primary outcome measure, or any of the secondary outcome measures. However, an overall significant improvement in SRS total raw score was observed from baseline to end of treatment for the entire group of children with ASD. This suggests a need to further study the efficacy of the social skills training protocol. Limitations to the current study and areas for future research are discussed. Trial registration: ClinicalTrials.govNCT01086475.
    Full-text · Article · Dec 2016 · Molecular Autism
    • "Dimensional evaluation can be a more successful approach to encompass the features of RRBs than using diagnostic categories in research and clinical settings. In fact, various studies have used the RBS-R as a simple, useful instrument for evaluating RRBs in clinical trials on ASD treatment efficacy (Anagnostou et al., 2012; Dawson et al., 2010; Hardan et al., 2012), examinations of RRB subcategories (Bishop et al., 2012; Lam & Aman, 2007; Lam, Bodfish, & Piven, 2008), and research on the relationship between RRBs and associated ASD clinical features (Gabriels, Cuccaro, Hill, & Ivers, 2005). The RBS-R-Japanese version (RBS-R-J) has already been translated, back-translated, and authorized. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Restricted and repetitive behaviors (RRBs) constitute a core symptom of autism spectrum disorder (ASD). The Repetitive Behavior Scale-Revised (RBS-R) is a widely used questionnaire administered by parents or caregivers to assess RRBs in individuals with ASD. This study evaluated the psychometric properties of the RBS-R Japanese Version (RBS-R-J). The ASD and non-ASD groups comprised 274 and 36 participants, respectively. We examined corrected item-total correlation, Cronbach's alpha, and RBS-R-J scores of different diagnostic groups, as well as correlations between RBS-R-J scores and intelligence quotient (IQ), autistic symptoms, adaptive/maladaptive functioning, aberrant behaviors, and sensory processing. All items showed moderate corrected item-total correlations. Cronbach's alpha coefficient was .93. We found significant differences in the mean RBS-R-J scores of the low-functioning ASD group and the intellectual disabilities group, and of low-functioning and high-functioning ASD groups. RBS-R-J scores negatively correlated with IQ and scores on the Sensory Profile (Japanese version) and Adaptive Behavior Composite of the Maladaptive Behavior Index of the Vineland Adaptive Behavior Scales-Second Edition (VABS-II; Japanese version), but positively correlated with scores on the peak and current symptoms subscales of the Pervasive Developmental Disorders Autism Society Japan Rating Scale, the VABS-II, and the Aberrant Behavior Checklist-Community (Japanese version). From these results, we conclude that RBS-R-J showed good reliability, diagnostic validity, and convergent validity, indicating that it is a reliable, valid instrument for use among ASD individuals in clinical and research settings.
    No preview · Article · Jul 2015 · Research in Autism Spectrum Disorders
  • Source
    • "The presence of such a correlation would be evidence in favor of the correctness of our assumptions. Second, the literature has some indications of poss itive results of antioxidant therapy in early childhood autism (Chez et al., 2002; Dolske et al., 1993; Morris and Agin, 2009; Yui et al., 2012; Hardan et al., 2012). It is of interest to study the impact of antioxidant therr apy in a sample of children who have undergone assessment of the genomic dose of active ribosomal genes. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Ribosomal genes (RG), or rRNA genes, in eukaryotic genomes are represented by numerous tandem repeats, of which only a portion are transcriptionally active. The number of active copies is a constant feature of genome genome determining the cell’s ability for the rapid synthesis of proteins needed to overcome the effects of stress. A low number of active RG copies leads to reduced stress resistance and elevated risk of multifactorial diseases (MFDs). Oxidative stress (OS) in the brain cells is believed to be involved in the pathogenesis of infantile autism (IA) and schizophrenia, that is, MFDs with severe genetic predisposition. With autism, OS markers are detected almost in every study, while with schizophrenia the OS data are contradictory. In a sample of patients with schizophrenia, we previously found a significantly higher quantity of active RG copies than in the population on average. In this work, we have determined the number of active RG copies in a sample of patients with IA (n = 51) and revealed a significantly lower mean value than in a healthy population. A novel mathematical model of the dynamic pattern of OS has been proposed. This model was implemented as a system of ordinary differential equations and assumes the induction of antioxidant protection enzymes being mediated by reactive oxygen species (ROS), with a subsequent decrease in the intracellular concentration of ROS. The rate of synthesis of antioxidant protection enzymes is limited by the ribosome synthesis rate, which depends on the number of active RG copies. Analysis of the model showed that the system always approaches a single point of stable equilibrium via the mechanism of damping oscillations, which to a certain extent resembles the dynamics of “predator-prey” interaction in the Lotka-Volterra model. The equilibrium ROS level inversely depends on the number of active RG copies. Our study allows us to explain the inconsistency of clinical data when detecting OS in IA and schizophrenia, suggesting a novel criterion for differential cytogenetic diagnostics of schizophrenia and IA, and to assume that antioxidant therapy should be effective only for children with a low number of active RG copies.
    Full-text · Article · Sep 2014
Show more